Zobrazeno 1 - 10
of 334
pro vyhledávání: '"Hideaki, Miyoshi"'
Autor:
Yoshiyuki Furukawa, Akio Horiguchi, Masayuki Shinchi, Kenichiro Ojima, Yusuke Hirano, Kazuki Takekawa, Hideaki Miyoshi, Yuhei Segawa, Keiichi Ito
Publikováno v:
Urology Video Journal, Vol 24, Iss , Pp 100290- (2024)
Objective: Bulbar urethral necrosis is a rare and devastating complication of anastomotic urethroplasty for pelvic fracture urethral injury, which manifests as bulbar urethral loss due to inadequate retrograde blood supply after transection of the bu
Externí odkaz:
https://doaj.org/article/c0068fd96fff42ae82c5151d5dfa70b4
Autor:
Yutaka Seino, Hideaki Miyoshi, Heidrun Bosch Traberg, T V S Divyalasya, Keiji Nishijima, Yasuo Terauchi
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 8, Pp 1321-1329 (2022)
ABSTRACT Aims/Introduction The present trial compared the efficacy and safety of once‐daily liraglutide 1.8 mg with liraglutide 0.9 mg in Japanese patients with type 2 diabetes to assess the incremental effects of liraglutide 1.8 mg in those who ex
Externí odkaz:
https://doaj.org/article/1fc252900df9478ab8966830b33cfd82
Autor:
Atsushi Tsuzuki, Yoichiro Fujioka, Aiko Yoshida, Sayaka Kashiwagi, Maho Amano, Tohru Hira, Akinobu Nakamura, Hideaki Miyoshi, Tatsuya Atsumi, Yusuke Ohba
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 7, Pp 1134-1139 (2022)
Abstract Live‐cell imaging with fluorescent proteins (FPs) is a powerful tool for investigating the exocytosis processes of hormones. However, the secretion process of glucagon‐like peptide‐1 (GLP‐1) has not been visualized by FPs, which migh
Externí odkaz:
https://doaj.org/article/76e8e4d4c29f48ae81fb2139c0372754
Autor:
Houman Goudarzi, Hirokazu Kimura, Hiroki Kimura, Hironi Makita, Munehiro Matsumoto, Nozomu Takei, Kaoruko Shimizu, Masaru Suzuki, Taku Watanabe, Eiki Kikuchi, Hiroshi Ohira, Ichizo Tsujino, Jun Sakakibara-Konishi, Naofumi Shinagawa, Noriharu Shijubo, Hirokazu Sato, Katsunori Shigehara, Kichizo Kaga, Yasuhiro Hida, Soichi Murakami, Yuma Ebihara, Akinobu Nakamura, Hideaki Miyoshi, Satoshi Hirano, Nobuyuki Hizawa, Tatsuya Atsumi, Shau-ku Huang, Yoichi M. Ito, Masaharu Nishimura, Satoshi Konno
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Introduction Club cell secretory protein-16 (CC16) is a major anti-inflammatory protein expressed in the airway; however, the potential role of CC16 on overweight/obese asthma has not been assessed. In this study, we examined whether obesity
Externí odkaz:
https://doaj.org/article/b24ac56df8c743198320499d83bdf572
Autor:
Yuki Yamauchi, Akinobu Nakamura, Takashi Yokota, Kiyohiko Takahashi, Shinichiro Kawata, Kazuhisa Tsuchida, Kazuno Omori, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Toshihisa Anzai, Shinya Tanaka, Yasuo Terauchi, Hideaki Miyoshi, Tatsuya Atsumi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract We aimed to determine the mechanism by which the sodium glucose co-transporter 2 inhibitor, luseogliflozin, preserves pancreatic beta-cell mass and function in db/db mice. Six-week-old db/db mice were fed to standard chow or standard chow co
Externí odkaz:
https://doaj.org/article/c1a2036c306a49faa4f57882e630c63f
Autor:
Tomonori Sekizaki, Hiraku Kameda, Hiroshi Nomoto, Kyu Yong Cho, Akinobu Nakamura, Kiyohiko Takahashi, Arina Miyoshi, Norio Wada, Jun Takeuchi, So Nagai, Hideaki Miyoshi, Tatsuya Atsumi
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 11, Pp 1978-1982 (2021)
Abstract Dipeptidyl peptidase‐4 (DPP‐4), namely CD26, is expressed on the surface of immune cells, suggesting that inhibition of DPP‐4 might affect the immune system. The current multicenter observational case–control study was carried out to
Externí odkaz:
https://doaj.org/article/94be6223aef645b6a02a091f2fdbd1b7
Autor:
Kyu Yong Cho, Tatsuya Atsumi, Hiroshi Nomoto, Jun Takeuchi, So Nagai, Akinobu Nakamura, Hideaki Miyoshi, Shinji Taneda, Aika Miya, Hiraku Kameda, Akihiro Takahashi, Hiroyoshi Kurihara
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 6 (2022)
Introduction Imeglimin is a novel anti-hyperglycemic drug that improves both insulin resistance and insulin secretion. The effects of imeglimin on glycemic control were confirmed in phase III clinical trials, but little is known about its effectivene
Externí odkaz:
https://doaj.org/article/97c4b01d827247b1bef0e3e070c8f9cd
Autor:
Kazuhisa Tsuchida, Akinobu Nakamura, Hideaki Miyoshi, Kelaier Yang, Yuki Yamauchi, Shinichiro Kawata, Kazuno Omori, Kiyohiko Takahashi, Naoyuki Kitao, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Yusuke Seino, Yasuo Terauchi, Tatsuya Atsumi
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 9, Pp 1545-1554 (2021)
Abstract Aims/Introduction We aimed to determine whether glucokinase is required for β‐cell mass expansion induced by high‐starch diet (HSTD)‐feeding, as has been shown in its high‐fat diet‐induced expansion. Materials and Methods Eight‐
Externí odkaz:
https://doaj.org/article/4a95baf82e6a47f19180c040641d7e6b
Autor:
Aika Miya, Akinobu Nakamura, Kyu Yong Cho, Shinichiro Kawata, Hiroshi Nomoto, So Nagai, Hajime Sugawara, Shinji Taneda, Kazuhisa Tsuchida, Kazuno Omori, Hiroki Yokoyama, Jun Takeuchi, Shin Aoki, Yoshio Kurihara, Tatsuya Atsumi, Hideaki Miyoshi
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 8, Pp 1395-1399 (2021)
Abstract Aims/Introduction To identify the effect of combination therapy with a dipeptidyl peptidase‐4 inhibitor and a sodium–glucose cotransporter 2 inhibitor compared with switching from a dipeptidyl peptidase‐4 inhibitor to a sodium–glucos
Externí odkaz:
https://doaj.org/article/2ade46145c304a1cb4788ecbd261113a
Autor:
Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura, Shinichiro Kawata, Hajime Sugawara, Jun Takeuchi, So Nagai, Kazuno Omori, Kazuhisa Tsuchida, Aika Miya, Ikumi Shigesawa, Kenichi Tsuchida, Shingo Yanagiya, Hiraku Kameda, Hiroki Yokoyama, Shinji Taneda, Yoshio Kurihara, Shin Aoki, Naoki Nishimoto, Tatsuya Atsumi, Hideaki Miyoshi
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 8, Pp 1417-1424 (2021)
Abstract Aims/Introduction We recently reported the beneficial effect of the combination of sodium–glucose cotransporter 2 inhibitor and dipeptidyl peptidase‐4 inhibitor on daily glycemic variability in patients with type 2 diabetes mellitus. Add
Externí odkaz:
https://doaj.org/article/3e8bdc46ba6e43f5ae3287bfe8db2f38